✦ LIBER ✦

Risk factors for fatal recurrence of liver transplant recipients with hepatocellular carcinoma in the first year

✍ Scribed by Wei-long Zou; Yun-jin Zang; Xin-guo Chen; Zhong-yang Shen

Book ID: 107466877
Publisher: Chinese Anti-Cancer Association
Year: 2007
Tongue: English
Weight: 197 KB
Volume: 19
Category: Article
ISSN: 1000-9604
DOI: 10.1007/s11670-007-0165-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

203Risk factors for recurrence of hepato

203Risk factors for recurrence of hepatocellular carcinoma after liver transplantation

✍ FIGUEIRA, E; LEITAO, R; SETANI, E; BITTERCOURT, P; LALLEE, M; QUINTELA, E; MASSA 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB

Risk factors for liver transplant waitli

Risk factors for liver transplant waitlist dropout in patients with hepatocellular carcinoma

✍ Sang-Jae Park; Chris E. Freise; Ryutaro Hirose; Robert K. Kerlan; Francis Y. Yao 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB

Genotyping of hepatocellular carcinoma i

Genotyping of hepatocellular carcinoma in liver transplant recipients adds predictive power for determining recurrence-free survival

✍ J. Wallis Marsh; Sydney D. Finkelstein; Anthony J. Demetris; Patricia A. Swalsky 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

Incidental Hepatocellular Carcinoma in L

Incidental Hepatocellular Carcinoma in Liver Transplant Recipients is Associated With Fatty Liver Disease and Conveys a Low Risk of Recurrent Malignancy After Transplant

✍ M.H. Levine; K. Enestvedt; P. Porrett; R. Cui; M. Hoteit; Y. Mu; E. Siegelman; S 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Analysis of risk factors for tumor recur

Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: Key role of immunosuppression

✍ Marco Vivarelli; Alessandro Cucchetti; Fabio Piscaglia; Giuliano La Barba; Luigi 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

To confirm recent observations about the relationship between immunosuppression and the recurrence of hepatocellular carcinoma (HCC) after liver transplantation (LT), we retrospectively analyzed 70 consecutive HCC patients who underwent LT and received cyclosporine (CsA) -based immunosuppression. Cs

Total tumor volume predicts risk of recu

Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma

✍ Christian Toso; James Trotter; Alice Wei; David L. Bigam; Shimul Shah; Joshua La 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB

Criteria for the selection of candidates for liver transplantation in the presence of hepatocellular carcinoma (HCC) should accurately predict posttransplant recurrence while not excluding excessive numbers of patients from candidacy. Existing criteria are challenged by the limited accuracy of radio